Equities

Amedisys Inc

Amedisys Inc

Actions
  • Price (EUR)89.50
  • Today's Change-1.00 / -1.10%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1264143
Total Receivables, Net328309287
Total Inventory------
Prepaid expenses151210
Other current assets, total282817
Total current assets497389357
Property, plant & equipment, net131119120
Goodwill, net1,2451,2871,196
Intangibles, net103101111
Long term investments666153
Note receivable - long term------
Other long term assets191920
Total assets2,0601,9761,857
LIABILITIES
Accounts payable284438
Accrued expenses303296323
Notes payable/short-term debt000
Current portion long-term debt/capital leases361513
Other current liabilities, total106--0
Total current liabilities474356374
Total long term debt362419432
Total debt398435445
Deferred income tax4120--
Minority interest535545
Other liabilities, total647474
Total liabilities994925926
SHAREHOLDERS EQUITY
Common stock0.040.040.04
Additional paid-in capital787755728
Retained earnings (accumulated deficit)748758639
Treasury stock - common(469)(461)(436)
Unrealized gain (loss)------
Other equity, total------
Total equity1,0671,052931
Total liabilities & shareholders' equity2,0601,9761,857
Total common shares outstanding333333
Treasury shares - common primary issue5.465.375.16
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.